Intravenous Dexmedetomidine as an Adjunct to Neuraxial Anesthesia in Cesarean Delivery: A Retrospective Chart Review

Table 1

Patient demographics and surgical characteristics.

	Dexmedetomidine	Others	value
Total number of patients	62	45
Age (years)	31 (29, 34)	32 (29, 36)	0.22
Gestational age	39 (37, 39)	39 (36, 39)	0.58
Race
Caucasian	54 (87%)	35 (78%)	0.3
African American	2 (3%)	3 (7%)	0.65
Hispanic	1 (2%)	1 (2%)	1.00
Asian/Pacific Islander	3 (5%)	2 (4%)	1.00
African	1 (2%)	2 (4%)	0.57
Others	1 (2%)	2 (4%)	0.57
Body mass index	34.2 (28.0, 40.0)	32.6 (28.1, 39.0)	0.67
Gravidity	2 (1, 3)	2 (2, 4)	0.82
Parity	2 (1, 2)	2 (1, 3)	0.42
Indication for cesarean delivery
Elective	2 (3%)	3 (7%)	0.65
Repeat	19 (31%)	14 (31%)	1.00
Malpresentation	4 (6%)	4 (9%)	0.72
Failure of vaginal delivery	21 (34%)	12 (27%)	0.53
NRFHT	8 (13%)	10 (22%)	0.30
Others	8 (13%)	2 (4%)	0.19
Number of previous cesarean deliveries
Primary	37 (60%)	23 (51%)	0.43
Repeat	25 (40%)	22 (49%)	0.43
Length of surgery (min)	71 (53, 86)	70 (58, 89)	0.44
Type of anesthesia
Spinal	33 (53%)	26 (58%)	0.70
Preexisting epidural	29 (47%)	19 (42%)	0.70
Emergency status
Emergent	35 (56%)	24 (53%)	0.84
Nonemergent	27 (44%)	21 (47%)	0.84
Conversion to general anesthesia	4 (6%)	4 (9%)	0.72

Median (Q1, Q3), Wilcoxon rank-sum test. n (%), Fisher’s exact test.